$ALDX Possible reasons for tomorrow's call. 1. In mid March the company said "Aldeyra also announced that, in response to a recent U.S. Department of Health and Human Services solicitation, Aldeyra has submitted a proposal to the Biomedical Advanced Research and Development Authority (BARDA) for the development of ADX-629 for the treatment of COVID-19 infection." BARDA accepted their proposal and willing to find the trial. 2. In mid April the company said " In addition, Aldeyra has filed ADX-629 under the FDA’s Coronavirus Treatment Acceleration Program (CTAP). " I think the company received a positive response from either one of the two submissions. I hope it is the first because it will have a dollar value attached to it and this will fly ...
  • 7
7 Likes